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Summary
Objectives: To investigate the frequency of chondrocyte apoptosis in equine articular cartilage (AC) specimens and to examine the relation-
ship between the process of cell death and the degree of cartilage degradation using a direct quantiﬁcation of numbers of apoptotic cells and
expression of active caspase-3.
Methods: AC from equine metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) joints was used and
each joint was graded macroscopically for cartilage degradation (macroscopic osteoarthritis (OA) score). Cartilage sections were graded using
a ‘modiﬁed’ Mankin scoring system. Apoptosis of chondrocytes in cartilage sections was assessed morphologically by appearance of apopto-
tic features (direct method) and by expression of active caspase-3 using indirect immunohistochemistry.
Results: The extent of apoptosis assessed by the direct method did not show any relationship with increasing severity of OA (P¼ 0.72). How-
ever, there was a signiﬁcant positive correlation between ‘modiﬁed’ Mankin score and apoptosis determined by caspase-3, with the extent of
apoptosis found to increase linearly with increasing severity of OA (r¼ 0.44, P¼ 0.0043). Caspase-3 expression was found to be signiﬁcantly
higher in the superﬁcial and middle zones than in the deep zone (P< 0.001). In the superﬁcial, middle and deep zones, expression of cas-
pase-3 was signiﬁcantly higher in the MCP joint than in the PIP joint (P¼ 0.013, P¼ 0.0018 and P¼ 0.029, respectively). Within the MCP
joints, apoptosis was higher in the lateral compartment compared to the medial (P¼ 0.053).
Conclusions: The data presented in this study demonstrate that chondrocyte apoptosis is positively associated with degree of cartilage matrix
damage and that the extent of apoptosis varies with cartilage zones and mechanical loading environment of the joint.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Abbreviations: AC articular cartilage, DIP distal interphalangeal, ECM extracellular matrix, GAG glycosaminoglycan, IL-1b interleukin-1b,
MCP metacarpophalangeal, OA osteoarthritis, PBS phosphate buffered saline, PIP proximal interphalangeal, S.E.M. standard error of
mean, TNF-a tumour necrosis factor-a, TUNEL terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labelling.Introduction
Chondrocytes are the only cell type resident in articular car-
tilage (AC). As a result, they are solely responsible for the
synthesis and maintenance of AC extracellular matrix
(ECM). Furthermore, chondrocytes regulate the enzymatic
breakdown of the ECM, hence maintaining the equilibrium
between synthetic and degradative processes. Loss of
homeostasis in favour of catabolic activities leads to the
destruction of AC characteristic of the slowly progressive,
degenerative joint disease, osteoarthritis (OA). Conse-
quently, chondrocyte death has been postulated to be a cru-
cial event in the pathogenesis of OA1,2. The mechanism of
cell death in OA has received considerable attention,
particularly in the last 10 years. Necrosis was originally
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Received 10 April 2006; revision accepted 17 June 2006.27postulated as the predominant pathway; however, more re-
cent studies intimate that cell death occurs primarily by
apoptosis or apoptosis-like programmed cell death1e6.
There is a wide range of reported frequencies of apopto-
tic cells in osteoarthritic cartilage and results are not in
good agreement. For example, Heraud et al.4 reported
a mean apoptosis of 18.1% in human osteoarthritic hip carti-
lage, whilst a more recent study found a considerably re-
duced rate of apoptosis in similar cartilage specimens6.
Numerous methods exist and are employed for the detec-
tion of apoptotic cells, this being the most likely cause of
discrepancies and inconsistencies in data recorded.
Terminal deoxynucleotidyl transferase (TdT)-mediated de-
oxyuridine triphosphate nick-end labelling (TUNEL) is per-
haps the most commonly used. Problematically, it has
been reported that the TUNEL assay is prone to technical
errors and is highly dependent on various technical as-
pects such as TdT enzyme concentration and proteinase
K digestion7. Furthermore, it appears that TUNEL is not
speciﬁc for apoptosis and has been shown to label non-
apoptotic cells8e10. In summary, accurate quantiﬁcation
of numbers of apoptotic cells using a robust method is re-
quired to determine the precise role apoptosis plays in
the pathogenesis of OA.
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pases is the central component of the apoptotic machinery.
Indeed, Roach et al.11 deﬁnes caspases as ‘the execu-
tioners of cell death’. The 14 caspases identiﬁed in mam-
mals thus far can be divided into three groups; the
apoptotic initiators (caspases 2, 8, 9 and 10), the apoptotic
executioners (caspases 3, 6 and 7) and the cytokine pro-
cessors (caspases 1, 4, 5, 11, 12, 13, 14). There are three
pathways that signal a cell to undergo apoptosis, each of
which are expressed by chondrocytes. Caspase-3 is
a downstream caspase which is activated by each of the
cell death pathways, and in its active form is one of the
key mediators of apoptosis in its execution phase. Cas-
pase-3 immunohistochemistry has been used to identify ap-
optotic cells in several recent studies6,12 and may represent
a means by which apoptotic chondrocytes may be correctly
identiﬁed and allows distinction between cells that have
died by other mechanisms.
The aim of this study was to investigate the incidence of
chondrocyte apoptosis in equine AC specimens and exam-
ine the relationship between the process of cell death and
the degree of cartilage degradation using direct quantiﬁca-
tion of numbers of apoptotic cells and expression of active
caspase-3 (hereafter referred to as caspase-3) as methods
of apoptosis detection.
Materials and methods
AC SAMPLING
The study comprised two populations of equine AC. No
information was available regarding the ages and genders
of the horses in population 1. Of the nine horses in popula-
tion 2 the mean age was approximately 10.4 (5.7) years,
of which ﬁve were male and four were female.
Population 1 consisted of equine left metacarpophalan-
geal (MCP), proximal interphalangeal (PIP) and distal inter-
phalangeal (DIP) joints obtained from horses (n¼ 10)
slaughtered at a local abattoir. It should be noted that for
each horse, cartilage from each of the three joints was
not always available. Cartilage from the PIP joint was avail-
able in all but one case, while MCP and DIP joints cartilage
were available in half the cases. The joints were opened
and the cartilage visually graded using a macroscopic OA
grading system proposed by Fuller et al.13.
Full depth cartilage samples, approximately 1 cm2, were
taken from weight-bearing areas of the joints. Samples
were placed in chilled isopentane and snap frozen immedi-
ately in liquid nitrogen, then stored at e70(C until required
for sectioning. Frozen cartilage samples were then embed-
ded in Tissue Tek OCT compound (Raymond A Lamb, UK)
and 7 mm thick sections cut on a cryostat (Bright Instruction
Company Ltd, Huntingdon, England), placed on Superfrost
Plus microscope slides (VWR International, UK) before
being left to air dry overnight.
Population 2 consisted solely of equine left MCP joints
(n¼ 9) also obtained from the local abattoir. The articular
surface was macroscopically graded as previously de-
scribed13. Cartilage was taken from six different regions of
the articular surface, as illustrated in Fig. 1. However, carti-
lage from each of the six regions for each horse was not al-
ways available. Regions A, D and E were available in most
cases while regions B, C and F were only available in two to
three cases. Cartilage samples were then frozen, stored
and sectioned as before. The time interval between slaugh-
ter and cartilage harvest was approximately 3 h for both
populations.HISTOLOGY
Haematoxylin and eosin/Safranin-O stained sections
were used to score samples for features of cartilage pathol-
ogy including changes in cellularity, structural abnormalities
and uptake of Safranin-O as a measure of glycosaminogly-
can distribution and loss, using a scoring system adapted
from Mankin et al.14 and Ostergaard et al.15 (Table I). The
calciﬁed cartilage and subchondral bone were not included
in the cartilage specimens; therefore, the evaluation criteria
‘Tidemark integrity’ was omitted. This gave a maximum total
score of 11 per cartilage specimen. Each specimen was
scored twice and the mean of the two scores used in any
analysis performed.
PHYSICAL METHOD OF APOPTOSIS DETECTION
Haematoxylin and eosin stained sections were used in
order to directly estimate numbers of apoptotic cells as
a ‘gold’ standard in this study. Apoptotic cells were classed
as those with morphology indicative of apoptosis including
membrane blebbing, nuclear condensation and cell
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Fig. 1. AC surface of a MCP joint showing the six different sampling
sites: centrolateral (A), centromedial (B), dorsolateral (C), dorsome-
dial (D), palmarolateral (E) and palmaromedial (F) regions.
Table I
‘Modified’ Mankin scoring criteria
Score
Structure
Intact surface 0
Surface ﬁssures 1
Surface ﬁssures to mid zone 2
Surface ﬁssures to deep zone 3
Complete disorganisation 4
Cells
Normal 0
Clusters/cloning 1
Some hypercellularity 2
Hypocellularity 3
Stain: haematoxylin and eosin with Safranin-O
Normal 0
Slight reduction 1
Moderate reduction 2
Severe reduction 3
No dye noted 4
29Osteoarthritis and Cartilage Vol. 15, No. 1shrinkage using a Nikon Eclipse Microscope at 1000mag-
niﬁcation. Due to constraints on the availability of cartilage
sections this method was only performed on about half of
the total number of samples (n¼ 24).
IMMUNOHISTOCHEMISTRY
Indirect immunohistochemical staining was used to de-
tect expression of active caspase-3. After ﬁxation in ace-
tone and blocking in goat serum diluted 1:5 with
phosphate buffered saline (PBS), the primary antibody
(polyclonal rabbit anti-human active caspase-3, AF835,
R&D Systems, UK) was applied at a 1:100 dilution for 1 h.
This was followed by application of biotin-labelled second-
ary antibody (goat anti-rabbit, Sigma) and ExtrAvidin Alka-
line Phosphatase Conjugate (Sigma) at 1:100 dilutions for
30 min and Fast Red (Sigma) for 10 min. Haematoxylin
(Ehrlich’s) was used for counterstaining. For a negative
control, the primary antibody was omitted and PBS alone
applied. Sections were assessed by a ‘blinded’ observer us-
ing a Nikon Eclipse Microscope at 400 and 1000 magni-
ﬁcation. The percentage of chondrocytes staining positive
for caspase-3 was calculated by counting the number of
positively and negatively stained cells in each zone. Where
possible every chondrocyte per sample was counted, when
this was not possible, at least 350 cells per specimen were
assessed.
STATISTICAL METHODS
Linear regression analysis was used to assess the rela-
tionship between severity of OA and chondrocyte apopto-
sis. Pearson’s correlation was used to compare apoptosis
as determined by the two different methods. One-way
Analysis of Variance (ANOVA) with Tukey’s multiple
comparison test was used to compare differences in
capsase-3 expression between cartilage zones, to compare
expression in different joints and to analyse expression in
the different sampling sites of the MCP joint. A two tailed
un-paired t test was used to compare caspase-3 expression
in the lateral and medial sides of the MCP joint surface.
Results
Figure 2 shows typical images of cartilage sections corre-
sponding to different modiﬁed Mankin grades. Table II
shows numbers of joints assigned to each macroscopic
OA score group and the equivalent mean modiﬁed Mankin
score of each macroscopic OA score group. It shows that
the macroscopic OA grades assigned to each joint did not
correlate with the severity of AC destruction as given by
modiﬁed Mankin score.
Macroscopic OA changes were largely conﬁned to the
central regions of the MCP joint. Because of this, the data
were analysed to see if there was a relationship between
macroscopic OA score and modiﬁed Mankin score in these
regions alone (population 2), but no signiﬁcant relationship
was found. Furthermore, analysis carried out on cartilage
taken from all regions excluding the central areas (on which
the macroscopic OA scores were based) revealed no signif-
icant association. For population 2, for which demographic
data were available, association between ages, modiﬁed
Mankin score and apoptosis was investigated but none of
the correlations were signiﬁcant.
Twenty-four cartilage specimens were assessed for apo-
ptosis by the direct physical method. Of these, data fromall three cartilage zones were obtained for 13 samples.
Overall, the extent of apoptosis assessed by the direct
method did not show any relationship with increasing se-
verity of OA (r¼ 0.11, P¼ 0.72). When the data were ana-
lysed for each zone of cartilage, there were similarly no
trends evident. Furthermore, there was no signiﬁcant asso-
ciation between the extent of apoptosis determined by this
direct method and expression of caspase-3 (r¼ 0.5,
P¼ 0.096).
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Fig. 2. Images of cartilage sections of different modiﬁed Mankin
grades. (A) Microscopically normal carti lage (histological
grade¼ 0), (B) some loss of Safranin-O stain, slight disruption to
articular surface (arrow) (histological grade¼ 2), and (C) some
loss of Safranin-O stain, hypocellularity (*), some cloning (arrow)
(histological grade¼ 5).
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between ‘modiﬁed’ Mankin score and apoptosis determined
by caspase-3. A typical example of a caspase-3 positive
chondrocyte is illustrated in Fig. 3. Of the 41 cartilage spec-
imens assessed for expression of caspase-3, data from
each zone of AC were available for 38 specimens. Overall,
the extent of apoptosis (caspase-3 expressing chondro-
cytes) was found to increase linearly with increasing severity
of OA (Fig. 4) (r¼ 0.44, P¼ 0.0043). This relationship is con-
sistent and signiﬁcant for the superﬁcial, middle and deep
zones of AC (r¼ 0.36, P¼ 0.019; r¼ 0.49, P¼ 0.0011 and
r¼ 0.37, P¼ 0.023, respectively).
There were marked differences in caspase-3 expression
between the three cartilage zones, with the lowest number
of apoptotic chondrocytes detected in the deep zone
(Fig. 5). Caspase-3 expression was signiﬁcantly higher in
the superﬁcial and middle zones than in the deep zone
(P< 0.001). There was no signiﬁcant difference in expres-
sion between the superﬁcial and middle zones.
Figure 6 demonstrates a marked difference in overall cas-
pase-3 expression with joint type in the order
MCP>DIP>PIP. In the superﬁcial, middle and deep
zones the expression of caspase-3 was signiﬁcantly higher
in the MCP joint than in the PIP joint (P¼ 0.013, P¼ 0.0018
and P¼ 0.029, respectively).
Table II
Numbers of each type of joint assigned to each macroscopic OA
score group and the equivalent mean modified Mankin score of
each macroscopic OA score group
Macroscopic OA score
0 1 2 3
Population 1
Number
of joints
Joint DIP 3 1 1 0
PIP 7 2 0 0
MCP 1 2 1 0
Population 2
Joint MCP 2 1 4 2
Equivalent mean modiﬁed
Mankin score
3.85 6.17 4.97 4.38
Fig. 3. Image of a typical cartilage section stained for active cas-
pase-3 by indirect immunohistochemistry (magniﬁcation 1000).
The arrow head indicates a cell positive for caspase-3.To determine the variations of apoptosis within different
anatomical locations of the MCP joint, expression of cas-
pase-3 in different regions of the joint was analysed
(Fig. 7). Caspase-3 expression was highest in the centrolat-
eral and centromedial group and lowest in the dorsolateral
and dorsomedial group. The differences, however, were
not signiﬁcant. This relationship was consistent for the mid-
dle and deep zones. However, in the superﬁcial zone cas-
pase-3 expression was highest in the palmarolateral and
palmaromedial group and lowest in the centrolateral and
centromedial group.
Comparison of caspase-3 expression in the lateral and
medial regions of the MCP joint showed that overall expres-
sion was highest in the lateral side of the joint (Fig. 8). The
lateral group comprises all of the results for the dorsolateral,
centrolateral and palmarolateral regions and the medial
group comprises the dorsomedial, centromedial and pal-
maromedial regions. The relationship was not quite
signiﬁcant (P¼ 0.053) and was consistent for each zone
of AC.
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Fig. 4. Overall relationship ( ) between severity of Mankin score
and expression of caspase-3. The extent of apoptosis increased
linearly with increasing severity of OA (r¼ 0.44, P¼ 0.0043).
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Fig. 5. Zonal variation in apoptosis (error bars indicate standard
error of mean (S.E.M.)).
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The data presented in this study demonstrate that the
extent of apoptosis determined using active caspase-3 ex-
pression and degradation of AC is closely correlated, with
a high incidence of chondrocyte apoptosis noted in the se-
verely degenerated cartilage matrix. The extent of apopto-
sis is also related to the mechanical loading environment
of the joint.
The results using the direct physical method of apoptosis
detection did not show any association with severity of OA
as determined by the ‘modiﬁed’ Mankin score. There may
be a number of possible explanations for this, but the
most obvious being that the direct method is very subjective
and so a large number of samples would need to be ana-
lysed to see any signiﬁcant association. Moreover, it was
consistently noted that apoptosis values as quantiﬁed by
the direct method were lower than those determined by cas-
pase-3 immunohistochemistry, suggesting that the two
methods differ with regard to the stage of chondrocyte apo-
ptosis they measure. For example, expression of caspase-3
may occur prior to some of the features of apoptosis that
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Fig. 6. Variation in apoptosis levels in the MCP, PIP and DIP joints
(error bars indicate S.E.M.).
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Fig. 7. Variation in apoptosis in the centrolateral (A), centromedial
(B), dorsolateral (C), dorsomedial (D), palmarolateral (E) and pal-
maromedial (F) regions of the MCP joint (error bars indicate
S.E.M.). None of the variations between the different regions
were statistically signiﬁcant (P> 0.05).were used to identify apoptotic chondrocytes using the
physical method. Thus, the discussion below is based on
apoptosis as determined by caspase-3 expression, and se-
verity of cartilage damage determined the modiﬁed Mankin
score.
The macroscopic OA scores did not show any signiﬁcant
associations with either the modiﬁed Mankin scores or cas-
pase-3 expression. This may be because the macroscopic
OA score described the gross appearance of the joint as
a whole, rather than the speciﬁc cartilage sample. In order
to address this in future studies, individual scores could
be assigned to a speciﬁc particular cartilage site, with the
total joint score being a product of these individual site
scores. However, even when the data were analysed for
the central regions alone, where the cartilage damage
tended to occur, no associations were found with OA score.
It is difﬁcult to draw any ﬁrm conclusions here since this in-
volved a relatively low number of samples, most of which
were of the same OA grade.
Chondrocyte apoptosis in osteoarthritic cartilage has
been reported in dogs, humans, and horses1e6 and is con-
sidered to be one of the major factors in the pathogenesis
of the OA disease process. The detection of apoptosis has
received widespread attention and the speciﬁcity of
TUNEL; one of the main methods of detection currently
used has come into serious question, as studies suggest
it is not speciﬁc for apoptosis and is prone to labelling
non-apoptotic cells8e10. This study demonstrates, using
active caspase-3 immunohistochemistry as a previously
characterised and reliable method of apoptosis detec-
tion6,12 that there is close correlation between degradation
of AC and chondrocyte apoptosis. Indeed, the incidence of
apoptosis in the most severely degenerated cartilage was
approximately 44%; however, it remains unclear whether
chondrocyte apoptosis is a cause of, or the result of, car-
tilage matrix breakdown. The phenomenon of ‘anchorage
dependence’ dictates that cells require attachment to the
ECM or to each other for survival, function and growth;
otherwise they are committed to apoptosis. As loss of pro-
teoglycan and disruption of the collagen network are two
of the main pathologic features of cartilage degradation,
this provides an ample environment for the disturbance
of chondrocyte anchorage to the ECM16. In short, chon-
drocyte apoptosis may exacerbate existing cartilage
breakdown or indeed be at its cause, as chondrocytes
are the sole source of matrix renewal and maintenance,
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Fig. 8. Variation in caspase-3 expression in the lateral and medial
regions of the MCP (error bars indicate S.E.M.). The difference
was of borderline signiﬁcance (P¼ 0.053).
32 C. M. Thomas et al.: Apoptosis and cartilage degradationa decreased cell population would likely lead to an inferior
ECM.
Apoptosis in the superﬁcial and middle zones of AC was
found to be signiﬁcantly higher than that observed in the
deep zone. This is in agreement with Sharif et al.6 who
found the highest expression of caspase-3 in chondro-
cytes of the superﬁcial zone. This process may be the
result of cells in the superﬁcial zone undergoing greater
deformation than those found in deeper zones17,18 or the
fact that the parallel alignment of collagen ﬁbrils in the super-
ﬁcial zone may not confer the same protection afforded to
cells of the deep zone in which the collagen network is
arranged in a perpendicular conﬁguration. Another potential
cause is the likely heightened exposure of cells of the super-
ﬁcial zone when compared to those of the deep zone, to pro-
apoptotic cytokines produced by the synovium that reach the
cartilage via the synovial ﬂuid.
The principal causes of lameness in the equine popula-
tion are joint injury and joint disease, with a large proportion
of these being attributed to OA19,20. Of all the joints, the
MCP joint is the most common site of OA, having the largest
number of site-speciﬁc traumatic and degenerative lesions
of all limb joints19.
An interesting and perhaps signiﬁcant ﬁnding of this study
was that the MCP joint had the highest incidence of apopto-
sis across each zone of cartilage when compared to the PIP
and DIP joints, each of which is less commonly affected by
OA. Signiﬁcant differences across all zones were noted be-
tween the MCP and PIP joint. The basis for the increased
incidence of OA in the MCP joint may arise from the biome-
chanical loading during impact and in the early part of the
stance phase it is subjected to. At fast speeds horses trans-
mit all of their body weight through the MCP joint during one
phase of the stride19. It is reported to act as a propulsive
strut ‘bouncing’ at impact21.
Mechanical stimuli are key regulators of chondrocyte
function, with certain types of mechanical injury known to in-
duce chondrocyte apoptosis. OA lesions are often localised
to weight-bearing cartilage or sites of trauma; therefore re-
petitive mechanical overload is likely to be a key signal for
the initiation and progression of OA. Indeed, an increased
risk of OA is found in the obese, those with occupations in-
volving heavy lifting, and individuals who have suffered from
previous joint injury22,23. Our ﬁndings would suggest that
mechanical load of the joint is intrinsically linked to the ex-
tent of apoptosis and cartilage breakdown.
The second population of cartilage samples taken from
six different regions of the MCP joint articular surface was
used to examine joint site-related differences. Overall, apo-
ptosis was found to be highest in the central region (across
the transverse ridge) and lowest in the dorsal aspect of the
joint. This is notable as the central regions (A and B) were
those where any osteoarthritic lesions were normally ob-
served. Furthermore, the central areas of the articular sur-
face of the MCP joint are the most common site of OA
lesions, a pathological entity termed ‘transverse ridge OA’.
Various degenerative changes are observed, ranging from
mild ﬁbrillation to deep ulcerations that extend into the sub-
chondral bone19. None of the differences were, however,
signiﬁcant, possibly due to the limited availability of cartilage
samples in each group.
Further studies utilising a larger number of macroscopi-
cally normal joints are required to determine whether re-
gional differences in chondrocyte apoptosis exist and
whether this is linked to differences in composition, me-
chanical load and ultimately susceptibility to OA that exists
within the MCP joint.Interestingly, Todhunter et al.24 determined that the cen-
tral regions of the MCP had the greatest intensity of inter-
leukin-1b (IL-1b) and tumour necrosis factor-a (TNF-a),
followed by the palmar and then dorsal regions. Cas-
pase-3 expression showed similar regional differences.
IL-1b and TNF-a are pro-apoptotic molecules and have
been shown to induce apoptosis in AC chondrocytes25,26.
Likewise, when a selection of the cartilage specimens
used in this study was analysed for expression of various
cytokines it was noted that there was signiﬁcant difference
in the distribution of IL-1b (P< 0.003), TNF-a (P< 0.006),
TNF p55 receptor (P< 0.001) and IL-18 receptor
(P< 0.02) between articular surface regions, with the
highest percentage expression being in the central
regions27.
Apoptosis in each zone of AC was found to be higher in
the lateral compared to the medial side of the MCP joint, but
the differences were not signiﬁcant. Brommer et al.28 de-
duced that cartilage degradation was considerably more
pronounced at the medial than lateral side of the articular
surface of the MCP joint. However, a later study reported
no difference in cartilage degradation between the medial
and lateral aspects of the MCP joint21. Further studies are
required to fully assess whether apoptosis predominates
in the lateral or medial side of the joint, and whether this
is linked to differences in cartilage degradation in these
regions.
The study has a number of limitations; ﬁrstly, the primary
antibody used in this study was raised against human ac-
tive caspase-3 as anti-equine antibodies were unavailable.
Hence, the speciﬁcity of binding of anti-human antibodies
to equine antigens may be questionable. However, posi-
tive results were observed and the pattern of staining
was comparable to that noted in studies that have used
the same antibody12. Secondly, limited information was
available regarding the ages, genders and training back-
grounds of the horses used in the study and where such
data were available (e.g., population 2), lack of information
regarding the training/exercise background of the horses
meant that any signiﬁcant results between age, ‘modiﬁed’
Mankin score and apoptosis could not still be fully
explained.
Finally, although the vast majority of studies in the
area have reported signiﬁcant reduction in chondrocyte
apoptosis following speciﬁc caspase-3 inhibition29e31,
several recent studies have shown that general caspase
inhibitors were more effective in reducing apoptosis in
human chondrocytes than caspase-3 speciﬁc inhibi-
tors32e34. The latter studies imply that chondrocyte death
by apoptosis does not always involve caspase-3 expres-
sion and that different pathways of chondrocyte apopto-
sis may exist, some of which involve expression of
caspase-3 and others which do not. However, direct
comparison of results from these studies is difﬁcult as
the cell type, detection techniques and agents used to
induce apoptosis were different in each study. Further
studies are therefore required to conﬁrm whether chon-
drocyte apoptosis always involves expression of
caspase-3.
In conclusion, we have demonstrated that there is a signif-
icant positive correlation between severity of OA and apo-
ptosis, suggesting that this process plays an important
role in the pathogenesis of the disease process. We have
also shown that joint and indeed joint region differences in
the extent of apoptosis exist, which may be linked to biome-
chanical load and susceptibility to OA. Further studies are
required to conﬁrm this.
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